1/5
文档分类:通信/电子

predictors of availability of long-acting medication for opioid use disorder论文资料.pdf


下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

特别说明:文档预览什么样,下载就是什么样。

下载所得到的文件列表
predictors of availability of long-acting medication for opioid use disorder论文资料.pdf
文档介绍:
Drug and Alcohol Dependence 204 (2019) 107586

Contents lists available at ScienceDirect

Drug and Alcohol Dependence

journal homepage: www.elsevier.com/locate/drugalcdep

Predictors of availability of long-acting medication for opioid use disorder
T

Chelsea L. Shovera, , Keith Humphreysa,b

a Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd. (MC: 5717), Stanford, CA 94305, United States
b Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave (152-MPD), Palo Alto, CA 94304, United States


ARTICLE INFO ABSTRACT

Keywords: Background: The U.S. Food and Drug Administration has approved three long-acting medications for opioid use
Opioid use disorder disorder (MOUD): extended-release naltrexone (XR-NTX) in 2010, a subdermal buprenorphine implant in 2016,
Naltrexone and a depot buprenorphine injection in 2017. Long-acting MOUD options may improve adherence while re-
B
内容来自淘豆网www.taodocs.com转载请标明出处.
非法内容举报中心
文档信息
  • 页数5
  • 收藏数0 收藏
  • 顶次数0
  • 上传人学习的一点
  • 文件大小191 KB
  • 时间2021-05-21